Single-Dose ampicillin for cesarean section prophylaxis

Santiago Padilla, Michael R. Spence, Pedro J. Beauchamp

Research output: Contribution to journalArticle

Abstract

A single 2-g dose of ampicillin or a placebo identical in appearance was administered intravenously in a randomized, prospective, double-blind manner to 71 patients undergoing cesarean section. The solutions were given either on call to the operating room or during the intraoperative period. Postoperative morbidity from infection occurred in 59.4% of patients receiving placebo and in 14.7% of those receiving ampicillin (P<.0001). In those individuals undergoing primary cesarean section the incidence of infection with placebo was 65% and with ampicillin 6.3% (P<.0004). In patients undergoing repeat cesarean section the incidence was 53% in the placebo group and 22% in the treatment group (P>.05). There were no differences in the effectiveness of the drug whether given preoperatively or intraoperatively. Serious infections and wound infections were not encountered in patients receiving ampicillin.

Original languageEnglish (US)
Pages (from-to)463-466
Number of pages4
JournalObstetrics and Gynecology
Volume61
Issue number4
StatePublished - Jan 1 1983

Fingerprint

Ampicillin
Cesarean Section
Intraoperative Period
Placebos
Wound Infection
Operating Rooms
Infection
Morbidity
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Padilla, S., Spence, M. R., & Beauchamp, P. J. (1983). Single-Dose ampicillin for cesarean section prophylaxis. Obstetrics and Gynecology, 61(4), 463-466.

Single-Dose ampicillin for cesarean section prophylaxis. / Padilla, Santiago; Spence, Michael R.; Beauchamp, Pedro J.

In: Obstetrics and Gynecology, Vol. 61, No. 4, 01.01.1983, p. 463-466.

Research output: Contribution to journalArticle

Padilla, S, Spence, MR & Beauchamp, PJ 1983, 'Single-Dose ampicillin for cesarean section prophylaxis', Obstetrics and Gynecology, vol. 61, no. 4, pp. 463-466.
Padilla, Santiago ; Spence, Michael R. ; Beauchamp, Pedro J. / Single-Dose ampicillin for cesarean section prophylaxis. In: Obstetrics and Gynecology. 1983 ; Vol. 61, No. 4. pp. 463-466.
@article{f089c2f1bfbd4b9aa663b407715fb7ad,
title = "Single-Dose ampicillin for cesarean section prophylaxis",
abstract = "A single 2-g dose of ampicillin or a placebo identical in appearance was administered intravenously in a randomized, prospective, double-blind manner to 71 patients undergoing cesarean section. The solutions were given either on call to the operating room or during the intraoperative period. Postoperative morbidity from infection occurred in 59.4{\%} of patients receiving placebo and in 14.7{\%} of those receiving ampicillin (P<.0001). In those individuals undergoing primary cesarean section the incidence of infection with placebo was 65{\%} and with ampicillin 6.3{\%} (P<.0004). In patients undergoing repeat cesarean section the incidence was 53{\%} in the placebo group and 22{\%} in the treatment group (P>.05). There were no differences in the effectiveness of the drug whether given preoperatively or intraoperatively. Serious infections and wound infections were not encountered in patients receiving ampicillin.",
author = "Santiago Padilla and Spence, {Michael R.} and Beauchamp, {Pedro J.}",
year = "1983",
month = "1",
day = "1",
language = "English (US)",
volume = "61",
pages = "463--466",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Single-Dose ampicillin for cesarean section prophylaxis

AU - Padilla, Santiago

AU - Spence, Michael R.

AU - Beauchamp, Pedro J.

PY - 1983/1/1

Y1 - 1983/1/1

N2 - A single 2-g dose of ampicillin or a placebo identical in appearance was administered intravenously in a randomized, prospective, double-blind manner to 71 patients undergoing cesarean section. The solutions were given either on call to the operating room or during the intraoperative period. Postoperative morbidity from infection occurred in 59.4% of patients receiving placebo and in 14.7% of those receiving ampicillin (P<.0001). In those individuals undergoing primary cesarean section the incidence of infection with placebo was 65% and with ampicillin 6.3% (P<.0004). In patients undergoing repeat cesarean section the incidence was 53% in the placebo group and 22% in the treatment group (P>.05). There were no differences in the effectiveness of the drug whether given preoperatively or intraoperatively. Serious infections and wound infections were not encountered in patients receiving ampicillin.

AB - A single 2-g dose of ampicillin or a placebo identical in appearance was administered intravenously in a randomized, prospective, double-blind manner to 71 patients undergoing cesarean section. The solutions were given either on call to the operating room or during the intraoperative period. Postoperative morbidity from infection occurred in 59.4% of patients receiving placebo and in 14.7% of those receiving ampicillin (P<.0001). In those individuals undergoing primary cesarean section the incidence of infection with placebo was 65% and with ampicillin 6.3% (P<.0004). In patients undergoing repeat cesarean section the incidence was 53% in the placebo group and 22% in the treatment group (P>.05). There were no differences in the effectiveness of the drug whether given preoperatively or intraoperatively. Serious infections and wound infections were not encountered in patients receiving ampicillin.

UR - http://www.scopus.com/inward/record.url?scp=0020671748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020671748&partnerID=8YFLogxK

M3 - Article

C2 - 6828277

AN - SCOPUS:0020671748

VL - 61

SP - 463

EP - 466

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 4

ER -